The findings were independent of socioeconomic status.
Artificial intelligence feasible for localizing acute stroke lesions
Mar 27, 2024
GPT-4 generated accurate neuroanatomical localization and detailed clinical reasoning based on processing of raw text from H&P.
Nonphysician-implemented multifaceted intervention beneficial in HTN
Jun 20, 2024
Significant reductions were seen in total cardiovascular disease and all-cause mortality for those aged 60 years and older; significant reductions also were seen for those younger than 60 years.
Guidelines updated for prevention, management of atrial fibrillation
Dec 05, 2023
Lifestyle and risk factor modification was recognized as pillar of a-fib management for preventing onset, progression and adverse outcomes.
Dementia risk score developed in UK Biobank, Whitehall cohorts
Aug 25, 2023
Score had strong discriminatory accuracy in U.K. Biobank test sample and Whitehall cohort, with AUCs of 0.80 and 0.77
Omega-3 fatty acid concentration linked to cognitive function
Oct 05, 2022
In predominantly middle-aged cohort, higher omega-3 index linked to larger hippocampal volumes, better abstract reasoning
ADA: Bempedoic acid cuts MACE in statin-intolerant patients
Jun 26, 2023
Significant risk reduction was observed in the primary end point of composite of cardiovascular death nonfatal myocardial infarction, nonfatal stroke, coronary revascularization.
ACP: Recommendations developed for newer type 2 diabetes medications
Apr 22, 2024
A strong recommendation was given for the addition of an SGLT-2 or GLP-1 agonist to metformin, and lifestyle modifications.
Cannabis use linked to adverse cardiovascular outcomes
Feb 28, 2024
Proportionately lower log odds were seen for heart disease, heart attack, stroke and composite outcome for days of use between zero and 30 a month.
Second death in trial of experimental Alzheimer’s drug raising concerns
Nov 29, 2022
Doctors suspect that by stripping away amyloid deposits, lecanemab weakens blood vessels and leaves them vulnerable to bleeds.